To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 205 participants.
Also called NCT03261375
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 205 participants
- Sponsor
- Shanghai Golden Leaf MedTec Co. Ltd
- Registry
-
NCT03261375
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03261375. Randomized; double masking; primary purpose treatment. Start 2021-01-19 (actual); primary completion 2022-12-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension
- Condition
- Hypertension
- Intervention (Device)
- Renal Artery Radiofrequency Ablation System (Generator and Catheter )
- Intervention (Drug)
- Antihypertensive Agents
- Intervention (Device)
- Sham Procedure
- Lead sponsor
- Shanghai Golden Leaf MedTec Co. Ltd
Record details
- Record id
cardio:ct-nct03261375- Content hash
0e4954e488a3432947524f77039710fad227a85dfc20c4050f94dea3f9da9ee6